The role of the thymus in immunosenescence: lessons from the study
































The role of the thymus 
 
The thymus is a central lymphoid organ in humans. It is 
devoted to thymocyte differentiation and maturation, 
and is therefore the primary source of circulating T 
lymphocytes. Anatomically, the thymus is located in the 
upper anterior portion of the thorax, just behind the 
sternum and in front of the great vessels. Its weight in 
proportion to body weight is greatest shortly before 
birth. Although its size continues to increase until it 
reaches its maximum absolute weight during puberty, 
its functional compartments (the medulla and the 
cortex) and T cell output activity diminish after the first 
years of life onwards. Subsequently, the thymus 
undergoes a process known as involution, which is 
defined as a decrease in the size, weight and activity of 
the gland with advancing age. Thymic involution is 
thought to result from high levels of circulating sex 
hormones in particular during puberty, lower population 
of precursor cells from the bone marrow and changes in 
thymic microenvironment. Although it continues to 


































throughout adulthood [1], the thymus largely 
degenerates into fatty tissue in elderly adults [2]. Since 
the atrophy of this organ and the reduction of its activity 
are natural processes which start relatively early in life, 
its importance beyond the initial production of T cells 
has remained a matter of debate and its role during 
adulthood has even be disregarded. 
 
Congenital heart defects and thymectomy  
 
In order to facilitate the surgical correction of life-
threatening congenital heart defects (CHD), it is 
common to ablate this gland, a process known as 
thymectomy. CHD is one of the most common defects 
at birth. The Children's Heart Foundation estimates that 
nearly one of every 100 babies is born with a CHD 
(http://www.childrensheartfoundation.org/). CHD in-
clude a number of problems: septal defects, defects 
causing obstruction in the heart or blood vessels, 
cyanotic defects or even complex abnormalities. Some 
of these defects are mild and may need little or no 
medical treatment even through adulthood. But others 
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time. In this case, invasive surgery to correct the defect 
remains the solution of choice. However, surgical 
access to the heart and great vessels is obstructed by the 
thymus, particularly after birth or during infancy when 
it occupies the largest relative space. The thymus is thus 
removed to access the heart region in order to repair the 
defect. Over the last 30 years, open heart surgery in 
newborns has become an increasingly safe and routinely 
performed surgical procedure, in particular since there 
has been no clinical report of immune disorders (e.g. 
immunodeficiency) as a consequence of thymectomy in 
CHD subjects [3, 4]. In rodents, it has long been shown 
that thymectomy can result in partial immuno-
deficiency, mainly affecting cell mediated immune 
responses [5]. However, rodents are born with a 
relatively immature immune system and an imcomplete 
TCR repertoire, whereas human newborns should have 
already a fully developed TCR repertoire diversity at 
birth [6, 7]. Young adults thymectomized during early 
childhood represent nonetheless a particularly 
informative group to evaluate the importance of the 
thymus beyond the production of the initial T cell stock, 
and to study the long-term consequences of early 
thymectomy in adult life. 
 
Consequences on the T cell compartment 
 
A number of studies have shown that thymectomy in 
infants results in alterations of the peripheral T cell 
compartment characterized by reduced CD4+ and CD8+ 
T cell counts, affecting mainly the naive T cells 
identified through the expression of CD45RA CD62L 
CCR7 and CD27 [8-14]. Decrease of naive CD4+ T 
cells was found to depend on chronological age and 
time post thymectomy [13]. Moreover, thymectomized 
individuals present decreased proportions of CD4+ T 
cells expressing CD31 or CD103, or displaying  T cell 
receptor excision circles (TREC) contents (i.e. markers 
of recent thymic emigrants)
  [9, 13, 14]. These 
alterations are attributed to the loss of thymic function, 
with an increase of peripheral proliferation of naive T 
cells. Analyses of the TCR repertoire revealed also a 
marked reduction in diversity within the CD8+ T cell 
compartment in some thymectomized patients, close to 
the changes found in individuals of old age, reflecting 
the accumulation of oligoclonal memory T cell 
populations in the periphery [14]. In a study with 20 
cardiac transplants recipients, who had thymectomy 1 to 
10 years prior to transplantation, a restricted TCR 
repertoire was also reported [12]. Regulatory 
CD4+CD25+ T cell numbers have been shown to be 
reduced in thymectomized patients, despite no apparent 
change in the proportions of the naive regulatory T cells 
(CD4+CD25+CD62L+) [11, 14]. It is possible that 
regulatory T cells mature earlier in life than other CD4+ 
T cells, and thus, may be less influenced by 
thymectomy. On the functional side, lymphocytes of 
thymectomized patients show an appropriate 
proliferative response to tetanus toxoid and phyto-
hemagglutinin [8, 9]. Moreover, already existing 
memory T cells (e.g. specific for persisting viruses like 
EBV) in thymectomized patients present regular 
functional and phenotypic attributes; thus thymectomy 
does not seem to prevent the normal development of 
memory T cells [14]. Overall, these findings highlight a 
reduced production of naïve CD4+ and CD8+ T cells, 
and a disequilibrium of the naïve to memory T cell 
ratio, as consequences of thymectomy. 
 
Thymectomy and the heterogeneity of profiles 
 
Importantly, studies on thymectomized individuals 
show also that there is a certain degree of heterogeneity 
between donors with regard to immunological 
attributes: some thymectomized individuals present 
satisfactory naïve T cell counts (i.e. close to non-
thymectomized controls) despite no signs of thymic 
regeneration, while other donors present marked 
alterations. Despite their young age, some patients can 
have indeed profound perturbations that are typically 
associated with advanced aging (i.e. > 75 years old): 
decreased T cell count and very low naïve T cell 
frequency, reduced T cell repertoire diversity, and 
increased numbers of highly differentiated memory T 
cells with shortened telomeres [14]. Several factors may 
explain the heterogeneity between thymectomized 
patients in terms of immune phenotype and the 
maintenance of the peripheral naïve T cells in some 
donors. First, cervical extensions of the thymic tissue 
may remain in situ and contribute to the influx of naïve 
T cells; second, T cells may be generated de novo at 
extrathymic sites; third, human recent thymic emigrants 
generated before thymectomy may be long-lived and 
persist for decades; and fourth, antigen-independent 
homeostatic proliferation in the periphery
  may 
compensate for the loss of thymic output in 
thymectomized patients. Nonetheless, extrinsic factors 
that impact indirectly on the level of naïve T cells and 
thus the function of the thymus may also be 
contemplated. Of note, a recent publication shows that 
exacerbated alterations in the T cell compartment in 
young adults thymectomized after birth were observed 
in those who were cytomegalovirus (CMV) seropositive 
[14]. Although an increased risk of acquiring CMV due 
to a potentially weakened immunity associated with 
thymectomy cannot be excluded, this marked 
immunosenescent phenotype is most likely the direct 
consequence of CMV infection through the 
establishment of an anti-CMV immune response in 
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impose a particular strong pressure on the immune 
system in normal healthy individuals [15]. CMV 
infection results in a massive expansion of CMV 
specific memory T cells, which can start from the early 
days of life and can reach up to 40% of total T cells 
during chronic infection [16]. Normal healthy adults 
infected with CMV present generally reduced 
proportions of naïve T cells and an accumulation of 
highly differentiated memory T cells associated with a 
loss of T cell repertoire diversity compared to CMV 
seronegative controls [17]. CMV infection is connected 
to the phenomenon of memory inflation, which is 
characterized by a progressive increase in the number of 
CMV specific memory T cells during chronic infection, 
with the continuous recruitment of naïve T cells, as 
shown in the murine CMV infection model [18]. In the 
context of inadequate T cell renewal due to 
thymectomy, CMV infection may thus lead to 
premature exhaustion of the naïve T cell compartment 
and loss of T cell repertoire diversity. Thymectomized 
individuals infected with CMV represent obviously an 
extreme situation, nonetheless its study provides 
interesting insights underlying the long term 
consequences of infections on our immune system and 
the development of immunosenescence with age. We 
learn that beyond its role in the initial production of T 
lymphocytes, the capacity of the thymus to produce T 
lymphocytes is necessary to maintain the integrity of the 
cellular immunity in the face of recurrent challenges by 
pathogens during the course of life, and thus to delay 
the onset of immunosenescence. 
 
Immune risk profile 
 
Can thymectomy represent an immunological risk for 
CHD patients who underwent open heart surgery, in 
particular considering the high prevalence of CMV 
infection in the general population (50 to 80%)? To 
date, it is unclear whether thymectomized patients with 
a prematurely aged immune system are at greater risk to 
develop inflammatory diseases, autoimmunity, or 
cancer and may suffer from increased morbidity or 
mortality due infectious diseases and opportunistic 
pathogens, as this is observed with old age. Considering 
that some thymectomized patients present significant 
reductions in naïve T cell frequencies, immune 
responses to new antigens or vaccination may be 
diminished. In the elderly, poor responses to new 
infectious antigens and vaccinations have been 
explained by the reduction in recent thymic emigrants 
associated with immunosenescence [19]. Only one 
prospective cohort study analyzed the specific humoral 
immune response to a new antigen by immunizing 
thymectomized children with tick-borne encephalitis 
(TBE) vaccine [20]. The thymectomized children 
showed a significantly delayed primary immune 
response compared to age-matched, non-thymectomized 
children, similar to the findings of TBE vaccination in 
elderly patients after physiological thymus involution 
[21]. A decreased ability of thymectomized patients to 
respond appropriately to new antigens may gain more 
relevance in later life. It is important to bear in mind 
that the oldest thymectomized CHD patients are still 
young, since open heart surgery in newborns is a 
relatively recent surgical procedure (safely performed 
over the last 30-40 years). Follow-up programs (e.g. 
infection rates and antibody levels against vaccines) of 
thymectomized adults that reach older age will be 
required to establish if thymectomy represents a risk 
associated with higher than expected rates of age-
associated immune conditions. It is likely that patients 
with residual thymic tissue after heart surgery, late 
thymectomy or CMV seronegativity will have close to 
normal immune attributes and will develop no related 
clinical conditions. However, one may speculate that 
early and complete resection of the thymus followed by 
infection with CMV may have adverse consequences on 
the immune competence in the long run. Decreased  T 
cell count,  very low naïve T cell frequency, reduced T 
cell receptor repertoire diversity, and increased numbers 
of senescent like memory T cells, as found in CMV 
infected thymectomized patients, are clear signs of 
immune deterioration. These alterations of the T cell 
compartment are reminiscent of the immune risk 
phenotype (IRP), defined by gerontologists as a cluster 
of immune measures that are predictive of early all-
cause mortality in the elderly [22, 23]. In view of the 
immediate and obvious benefit of open heart surgery in 
the context of CHD, the adverse consequences of 
thymectomy may be considered as secondary. 
Nonetheless, partial resection of the thymus during 
cardiac surgery should be encouraged in order to limit 
premature aging of the immune system.  
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